A new method for optimizing automated insulin delivery in type 1 diabetes.
ADAPTIVE MOTIF-BASED CONTROL (AMBC): A FUNDAMENTALLY NEW APPROACH TO AUTOMATED TREATMENT OPTIMIZATION FOR TYPE 1 DIABETES
This study is testing a new way to improve insulin delivery for people with type 1 diabetes by using smart technology that learns from your unique blood sugar patterns, helping to keep your levels more stable and manageable.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Virginia NIH-funded |
| Lab location | 1 site (Charlottesville, United States) |
| Project ID | NIH-11095891 on NIH RePORTER |
What this research studies
This research focuses on developing an innovative approach called Adaptive Motif-Based Control (AMBC) for optimizing automated insulin delivery in individuals with type 1 diabetes. By analyzing both individual and population glycemic patterns, the AMBC aims to provide real-time treatment adjustments tailored to each patient's unique needs. The methodology involves classifying continuous glucose monitoring profiles into basic motifs and utilizing these patterns to enhance insulin delivery systems. This could lead to more effective management of blood sugar levels for patients.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals of all ages with type 1 diabetes who use or are interested in automated insulin delivery systems.
Not a fit: Patients with type 2 diabetes or those not using continuous glucose monitoring systems may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve blood sugar control and quality of life for individuals with type 1 diabetes.
How similar studies have performed: Previous research has shown success with automated insulin delivery systems, indicating a promising foundation for this novel approach.
Where this research is happening
Charlottesville, United States
- University of Virginia — Charlottesville, United States (Active)
Researchers
- Principal investigator: Kovatchev, Boris P — University of Virginia
- Study coordinator: Kovatchev, Boris P
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.